Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

43.10
-1.8600-4.14%
Post-market: 43.280.1800+0.42%19:59 EDT
Volume:22.69M
Turnover:988.86M
Market Cap:62.46B
PE:17.46
High:44.42
Open:44.13
Low:42.78
Close:44.96
52wk High:105.72
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:1.14
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.51
PE(LYR):22.22

Loading ...

Top News Today: Stocks Mixed as Oil Drop Offsets Chip Rout

Dow Jones
·
Jul 29

Boston Scientific (BSX) Recalls Rapid Refill Injection System Over Syringe Detachment Risk

Simply Wall St.
·
Jul 29

Boston Scientific Has Underappreciated Growth Drivers, UBS Says

MT Newswires Live
·
Jul 29

Movement Alert|Boston Scientific Rises 3.03% in Regular Trading, Global Restructuring Plan Disclosed Ahead of Earnings Release

Market Focus
·
Jul 28

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and The Ensign Group (ENSG)

TIPRANKS
·
Jul 28

Boston Scientific (BSX) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Jul 28

Analysts’ Top Healthcare Picks: Boston Scientific (BSX), Intuitive Surgical (ISRG)

TIPRANKS
·
Jul 28

Boston Scientific assumed with a Buy at UBS

TIPRANKS
·
Jul 28

Boston Scientific Unveils New Restructuring Plan, Expects Job Cuts

Reuters
·
Jul 28

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 28

Boston Scientific Launches 2026 Global Restructuring Plan

TIPRANKS
·
Jul 28

Boston Scientific Launches Global Restructuring Plan with $700 Million-$800 Million in Charges

Reuters
·
Jul 28

Boston Scientific Corp - Estimates $700 Mln-$800 Mln Pre-Tax Charges, $500 Mln Annual Pre-Tax Expense Reduction - SEC Filing

THOMSON REUTERS
·
Jul 28

Boston Scientific Corp - Company Expects Headcount Reductions from Restructuring - SEC Filing

THOMSON REUTERS
·
Jul 28

NYSE Order Imbalance 902873.0 Shares on Buy Side

THOMSON REUTERS
·
Jul 28

Boston Scientific’s FARAFLEX AFib Trial Steps Up the Pulsed Field Ablation Race

TIPRANKS
·
Jul 28

Boston Scientific Continues to See Competitive Pressures, Oppenheimer Says

MT Newswires Live
·
Jul 27

Movement Alert|Boston Scientific Rises 3.08% in Regular Trading, Pre-Earnings Optimism and Institutional Buy Ratings Support Shares

Market Focus
·
Jul 27

Boston Scientific is Maintained at Outperform by Oppenheimer

Dow Jones
·
Jul 27

Oppenheimer Trims Price Target on Boston Scientific to $85 From $90, Keeps Outperform Rating

MT Newswires Live
·
Jul 27